SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • October 13th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • New York
THIS SEPARATION AGREEMENT AND GENERAL RELEASE (this “Agreement and Release”) is made and entered into by and between Kevin Pollack (“Employee”) and Opiant Pharmaceuticals, Inc. (the “Company”).
SUPPLY AGREEMENT between OPIANT PHARMACEUTICALS, INC. and AEGIS THERAPEUTICS, LLC Effective Date: January 1, 2017Supply Agreement • October 13th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • California
THIS SUPPLY AGREEMENT (this “Supply Agreement”), is effective as of the Effective Date and entered into on June 22, 2017 (“Execution Date”), by and between AEGIS THERAPEUTICS, LLC, a California limited liability company (“Aegis”), and OPIANT PHARMACEUTICALS, INC., a Delaware corporation (“Opiant”).
ContractResearch & Development Services Agreement • October 13th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • Delaware
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “****”. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
Confidential Execution VersionLicense Agreement • October 13th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • California
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “****”. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
